Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001780081-25-000004

Director sold 40,472 shares at an average $26.98 ($1,092,058)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Krainer Adrian R. · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-14 Sale : show line 1 in the form 10b5-1 −19,790 $26.61 $526,693 384,928 D
2025-11-14 Sale : show line 2 in the form 10b5-1 −20,682 $27.34 $565,365 364,246 D
Open-market sales · 40,472 sh · avg $26.98 · $1,092,058
Loading xslF345X05/form4-11182025_091122.xml…